Wetzel Investment Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-100
Closed -$54K – 474
2024
Q2
$54K Hold
100
– – 0.03% 230
2024
Q1
$47.8K Hold
100
– – 0.03% 257
2023
Q4
$56K Buy
+100
New +$46.9K 0.03% 236

Other funds holding IDXX

Wetzel Investment Advisors's IDXX Position: Q3 2024 in Review

Wetzel Investment Advisors sold out of Idexx Laboratories (IDXX) in Q3 2024, closing a stake of 100 shares — an estimated $54K sold.

Wetzel Investment Advisors first reported a position in IDXX in Q4 2023 and held it in 3 quarters. The position peaked at $56K in Q4 2023. 1,116 funds tracked by Wall St. Rank hold IDXX as of Q3 2024.

  • Wetzel Investment Advisors reported no remaining Idexx Laboratories position as of Q3 2024 after selling out during the quarter.
  • Wetzel Investment Advisors sold 100 Idexx Laboratories shares in Q3 2024, an estimated $54K.
  • Wetzel Investment Advisors first reported a position in Idexx Laboratories in Q4 2023 and held it in 3 quarters.
  • Wetzel Investment Advisors's Idexx Laboratories position peaked at $56K in Q4 2023.
  • 1,116 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2024.

Based on Wetzel Investment Advisors's 13F filing for Q3 2024, filed 29 Oct 2024.